PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
1.01
0.00 (0.00%)
At close: Aug 19, 2025, 3:58 PM
1.00
-1.48%
After-hours: Aug 19, 2025, 04:38 PM EDT
PharmaCyte Biotech Income Statement
Financials in USD. Fiscal
year is
May - April.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -4.38M | -6.5M | -7.41M | -7.71M | -8.52M | -6.26M | -5.94M | -6.85M | -6.46M | -7.06M | -6.36M | -5.05M | -4.39M | -3.92M | -3.82M | -3.77M | -3.62M | -3.34M | -3.46M | -3.57M |
Interest Income | 1.42M | 1.93M | 2.56M | 3.07M | 3.4M | 3.37M | 3.13M | 2.67M | 1.94M | 1.3M | 710.7K | 297.15K | 157.65K | 71.08K | 25.62K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 30.66M | 20.25M | 22.68M | 26.94M | 334K | -1.14M | -1.28M | -5.95M | -4.32M | -5.61M | -5.66M | -4.76M | -4.24M | -3.78M | -3.72M | -3.69M | -3.55M | -3.34M | -3.46M | -3.58M |
Net Income | 30.66M | 20.25M | 22.68M | 26.94M | 334K | -1.14M | -494.29K | -4.73M | -3.09M | -4.39M | -5.18M | -4.71M | -4.19M | -3.73M | -3.72M | -3.69M | -3.55M | -3.34M | -3.46M | -3.58M |
Selling & General & Admin | 4.85M | 4.1M | 5M | 5.31M | 6.11M | 5.86M | 5.62M | 6.44M | 5.99M | 6.42M | 5.61M | 4.34M | 3.7M | 3.16M | 3.05M | 2.98M | 2.71M | 2.64M | 2.82M | 3.07M |
Research & Development | 438.42K | 405.87K | 414.4K | 398.96K | 407.43K | 399.12K | 317.78K | 413.75K | 468.54K | 636.73K | 749.37K | 706.6K | 690.94K | 757.14K | 773.19K | 789.29K | 916.25K | 693.63K | 632.84K | 499.46K |
Other Expenses | -906.43K | 2M | 2M | 2M | 2M | -1.31K | -1.37K | -2.91K | -4.96K | -6.54K | -7.17K | -6.59K | -4.28K | -2.71K | -2.08K | -1.6K | -1.88K | -1.88K | -1.88K | -1.88K |
Operating Expenses | 4.38M | 6.5M | 7.41M | 7.71M | 8.52M | 6.26M | 5.94M | 6.85M | 6.46M | 7.06M | 6.36M | 5.05M | 4.39M | 3.92M | 3.82M | 3.76M | 3.62M | 3.34M | 3.46M | 3.57M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.00 | 509.00 | 1.55K | 1.8K | 2.43K | 2.35K | 1.31K | 1.06K | 388.00 |
Selling & Marketing Expenses | 905.68K | 1.14M | 1.53M | 1.47M | 1.32M | 1.35M | 975.98K | 1.15M | 1.23M | 1.72M | 1.74M | 1.6M | 1.54M | 1.06M | 1.13M | 1.42M | 1.43M | 1.45M | 1.52M | 1.41M |
Cost & Expenses | 4.38M | 6.5M | 7.41M | 7.71M | 8.52M | 6.26M | 5.94M | 6.85M | 6.46M | 7.06M | 6.36M | 5.05M | 4.39M | 3.92M | 3.82M | 3.76M | 3.62M | 3.34M | 3.46M | 3.57M |
Income Tax Expense | n/a | n/a | -1.87K | -1.87K | -1.87K | -1.87K | -789K | -1.23M | -1.23M | -1.23M | -482.83K | -44.83K | -44.36K | -43.32K | 751.00 | -198 | -277 | -1.32K | -1.44K | -1.55K |
Shares Outstanding (Basic) | 6.8M | 6.96M | 7.64M | 7.87M | 8.04M | 8.61M | 10.83M | 12.6M | 16.79M | 19M | 20.59M | 20.83M | 15.52M | 21.67M | 17.36M | 1.59M | 1.56M | 1.56M | 1.54M | 1.12M |
Shares Outstanding (Diluted) | 6.8M | 6.96M | 7.64M | 7.87M | 8.35M | 8.61M | 8.77M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 5.18M | 1.59M | 1.56M | 1.56M | 1.54M | 1.12M |
EPS (Basic) | 2.67 | 0.75 | 0.54 | 0.67 | -1.77 | -1.46 | -0.81 | -0.64 | -0.17 | -0.24 | -0.28 | -0.25 | -0.81 | -1.35 | -1.81 | -2.37 | -2.52 | -2.57 | -3.03 | -3.62 |
EPS (Diluted) | 2.67 | 0.77 | 0.56 | 0.69 | -1.82 | -1.54 | -0.89 | -0.91 | -0.6 | -0.85 | -1 | -0.91 | -1.25 | -1.6 | -1.94 | -2.37 | -2.52 | -2.57 | -3.03 | -3.62 |
EBITDA | -4.38M | -1.99M | -2.9M | -3.2M | -4.01M | -5.48M | -4.38M | -4.85M | -4.32M | -5.68M | -5.73M | -4.83M | -4.31M | -3.77M | -3.72M | -3.69M | -3.55M | -3.34M | -3.46M | -3.58M |
EBIT | -4.74M | -4.86M | -5.77M | -5.71M | -6.52M | -6.26M | -5.94M | -6.85M | -6.46M | -6.98M | -6.23M | -4.89M | -4.24M | -3.77M | -3.72M | -3.69M | -3.55M | -3.34M | -3.46M | -3.58M |
Depreciation & Amortization | 3.34M | 6.37M | 5.41M | 5.71M | 6.52M | 4.39M | 5.94M | 6.85M | 6.46M | 5.48M | 4.79M | 3.47M | 2.81M | 3.92M | 3.82M | 3.76M | 3.62M | 3.34M | 3.46M | 3.57M |